CLRB icon

Cellectar Biosciences
CLRB

Overview Fund Activity

25 hedge funds and large institutions have $3.85M invested in Cellectar Biosciences in 2020 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 4 closing their positions.

Holders
25
Holders Change
+7
Holders Change %
+38.89%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
3
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$1.01M
2
WVP
2
Worth Venture Partners
New Jersey
$511K
3
SCM
3
Sio Capital Management
New York
$243K
4
CH
4
CVI Holdings
Delaware
$179K
5
QP
5
Quilter Plc
United Kingdom
$175K

Top Sellers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$0
2
Citadel Advisors
2
Citadel Advisors
Florida
$0
3
Morgan Stanley
3
Morgan Stanley
New York
$3K
4
Victory Capital Management
4
Victory Capital Management
Texas
$0
5
Bank of America
5
Bank of America
North Carolina
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Bank of America
26
Bank of America
North Carolina
– – -5 Closed
BlackRock
27
BlackRock
New York
– – – –
RCA
28
Ranch Capital Advisors
Florida
– – – –
AWM
29
AllSquare Wealth Management
New York
$0 1 – –
CFGS
30
Concourse Financial Group Securities
Alabama
– – – –
1
2